Targeting glycosaminoglycans in the lung by an engineered CXCL8 as a novel therapeutic approach to lung inflammation
Keywords: BAL; brochoalveolar lavage; COPD; chronic obstructive pulmonary disease; CF; cystic fibrosis; GAG; glycosaminoglycan; GM-CSF; granulocyte macrophage colony-stimulating factor; HMVEC-L; human lung microvascular endothelial cells; KC; keratinocytes-derived